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Technical Report
Abstract
Purpose: The objective of this work is to investigate the impact of collimator jawposition on dose to organs at risk (OARs) during a 3-dimensional conformalradiotherapy (3DCRT) of pancreatic cancer and postulate a method to minimizeOAR dose by proper positioning of the jaws. Methods: Clinically delivered 3DCRTtreatment plans for 10 patients optimized with multiple static beams usingmultileaf collimator (MLC) leaves conformed to a block margin around target, andcollimator jaws aligned with outer extent of the block margin were selected.Subsequent plans were generated by displacing the collimator jaws outward inlateral, superior-inferior or both directions by 1 and 2 cm without altering the MLCposition. Computed dose to OARs and target with unaltered dose normalizationwere compared against the corresponding dose obtained from the original plans.
Results: Outward displacement of the collimator jaws by 1 cm in lateral and/orsuperior-inferior direction resulted in a significant increase in mean dose to thestudied OARs. The increase was found to be proportional to the outwarddisplacement of the jaws. The increase in maximum dose to spinal cord wassignificant in a few patients while it was insignificant for all other OARs.
Conclusion: Collimator jaws aligned with outer extent of a block margin minimizedose to OARs. Any gap between the block margin and the collimator jaws can leadto an inadvertent delivery of higher dose to the OARs. Hence, the use of an optimaljaw position during treatment planning becomes important to all patient plans.
Keywords: 3D Conformal Radiotherapy; Pancreatic Cancer; Collimator Jaws; OARs;HD MLCs; Varian TrueBeam Linear Accelerator; Enhanced Dynamic Wedge (EDW)
1. IntroductionPancreatic cancer has been projected to become secondleading cause of cancer related death in the UnitedStates by 2030.1 Surgery alone is not an obvious optionfor pancreatic cancer treatment because of its aggressivebiology, late diagnosis, encasement of large bloodvessels and the presence of metastasis.2,3 Despite thehigh chances of distant metastases of pancreatic cancer,radiotherapy may provide a survival advantage.4Current radiation prescription dose (~ 54 Gy) is notadequate for the tumor control.5,6 One approach for
better tumor control is to increase the prescription dosebut that option comes at the cost of higher toxicity to theOARs.7 Hence reducing dose to OARs becomes extremelyimportant.Intensity modulated radiation therapy (IMRT) is atechnique that can spare critical structures well. Butsome studies suggest that IMRT did not present asignificant advantage over three dimensional conformalradiation therapy (3DCRT) in terms of OARs sparing.8
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There are also potential problems of low dose spreadover larger volume and higher leakage dose due to theusage of higher monitor units (MUs) during an IMRTtreatment. Nonetheless, selection of radiotherapytreatment modality depends on the staging of tumor andconfidence level of a physician among other factors; and3DCRT remains a widely used modality for treatingpancreatic cancer.Usually, tumors have a complex shape and collimatorjaws of a linear accelerator (LINAC) alone cannotconform to the targets. Multileaf collimators (MLCs)incorporated in modern LINACs offer a good conformitywith the target but leaf transmission leads to a higherradiation dose delivery as compared to the collimatorjaws. Rounded end MLCs suffer from biggertransmission penumbra and higher leaf-end radiationtransmission.9For the current standard prescription dose to the target,3DCRT plans usually meet the clinical standards.However, optimal jaw position can help reduce dose toOARs surrounding the target.10 Dose reduction to OARscan help escalate the prescription dose, or at leastreduce the chances of complication to the OARs.Minimum Y-jaw separation required for enhanceddynamic wedge (EDW) in some LINACs may not allowfor the use of an optimal jaw position in some of the3DCRT plans. This factor as well as a gap introducedbetween the jaws and a block margin during treatmentplanning can increase dose to the surrounding criticalstructures. Here we perform a quantitative assessmentof the effect of jaw position on dose to OARs and presenta method to minimize dose to the OARs during a 3DCRTtreatment of pancreatic cancer.
2. Methods and Materials
2.1 Patient populationTen pancreatic cancer patients treated with 3DCRT wereselected in random for the study. These patients wereimaged with a computed tomography (CT) simulator(Phillips Brilliance Big Bore, Amsterdam, Netherlands)for treatment planning. Treatment plans were generatedwith Eclipse treatment planning system (Version11.0.47, Varian Medical Systems, Palo Alto, CA) using theanalytical anisotropic algorithm (AAA). The patientswere treated to 45-50.4 Gy (1.8 Gy/fraction) using 18MV photon beam from a Varian TrueBeam STx LINACwith rounded leaf end 120 high-definition MLCs. OARs(left and right kidneys, stomach, liver, cord and bowel)and target (planning target volume- PTV) werecontoured.PTV volume among the patients ranged from 56 to 896cc. While uniform 7 mm margin around PTV was enoughfor intended target coverage in 8 patients, 8 mm wasneeded in 2 cases. Four to seven static beams (at fourcardinal angles, plus oblique gantry angles for additional
beams with collimator angles of 00 or 900) were used togenerate each treatment plan. The beam angles andEDW (a virtual wedge created by a computer controlledY-jaw movement and dose rate change in VarianLINACs) were used as needed in order to get good targetcoverage while minimizing dose to the OARs. Eachtreatment plan was normalized to cover 95% of PTVvolume by 100% of the prescribed dose with thecollimator jaws aligned with outer extent of the blockoutline as shown in Figure 1(a). Dose to PTV and OARswere evaluated with isodose distributions and dosevolume histograms (DVHs).
2.2 Research plansStarting from the clinical treatment plan, subsequentresearch plans were generated by translating twoopposite jaws away from the treatment field. The jawswere moved in superior-inferior (refer Figure 1(b)),lateral or both directions by 1 cm and 2 cm. Note thatthe MLC positions were not altered in those plans. Doseto the target and OARs was calculated for every researchplan keeping the same PTV dose normalization.Preserved dose normalization did not alter MUs used inany of the treatment plans.
Figure 1: Collimator jaws (a) Aligned with the outer extentof a block margin around PTV in a clinical plan; (b)Displaced by 1 cm in superior inferior direction.Mean and maximum dose to the OARs for various jawpositions were obtained from the treatment planningsystem and compared against the corresponding doseobtained from the delivered clinical plans. As there weredifferences in mean and maximum dose to the OARs inthe research plans in comparison with the clinical plans,the significance of the differences was evaluated usingstatistical analysis.
2.3 Statistical analysisTest for normal distribution was performed usingShapiro-Wilk test in the R statistical package.11Statistical significance was tested for normallydistributed data using a paired Student’s T-test. For adistribution showing larger deviation from a normaldistribution, a Wilcoxon signed-rank test was used.Statistical significance was compared against a threshold
p-value of 0.05.
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3. ResultsRange of the change in mean dose to target and variousOARs due to lateral or superior-inferior displacement ofjaws by 1 cm are tabulated in Table 1. Changes in meandose to the OARs were larger than the changes inmaximum dose. The changes in dose were small and notso apparent in DVHs for the 1 cm jaw displacement.As evident from Table 1, mean dose to most of the OARsincreased approximately by 1% due to 1 cm outerdisplacement of the jaws. This increase was found up to5% in some cases. Student t-test and Wilcoxon signedrank test showed that the mean dose differences aresignificant (p < 0.02). Kidneys, stomach and cord dosewere most affected by an increased jaw margin. Theseeffects on most of the patients were smaller for largerstructures such as liver and bowels, and other structuresthat extend beyond 2 cm from the target. However, theincrease was up to 3.2% for liver in a patient. There wasinsignificant change in mean dose to the PTV, asexpected from the preservation of plan normalization.
Table 1: Range of percentage increase in mean dose (%∆Dmean) to PTV and OARs due to 1 cm jaw displacementalong the lateral or superior-inferior direction for 10patients.Structure %∆Dmean (Lateral) % ∆Dmean (Sup-inf)Lt. kidney 0.4–2.0 -0.2–0.8Rt. kidney 0.4–2.9 -0.1–2.0Bilat. kidney 0.3 –2.1 -0.1–0.9Cord 0.0–2.6 0.2–1.1Stomach 0.2 –1.3 0.5 –5.3Bowel 0.1–1.1 0.2–1.5Liver 0.3–1.2 -0.0–3.2PTV 0.0–0.1 -0.1The increase in mean dose from 1 cm and 2 cm lateraland superior-inferior displacement of jaws averagedover 10 patients are shown in Figure 2 and Figure 3respectively.
Figure 2: Effect of outward (lateral) displacement of jawson mean dose to OARs and target.
Figure 3: Effect of outward (superior-inferior)displacement of jaws on mean dose to OARs and target.Results from Figure 2 and 3 show that structures lyinglaterally outwards from the target (kidneys, and liver) inmost patients were less affected by the superior-inferiordisplacement of the jaws. An exception was the liverwhere higher increase in dose was observed in a patient.Likewise, liver and bowel were less affected by lateraljaw displacement. As evident from Figure 2, thepercentage increase in mean dose to the OARs increasedlinearly with the increase in outward lateraldisplacement of the jaws. Even though changes inmaximum dose to most of the OARs were small,meaningful changes were observed for cord in fewpatients. Maximum dose, a limiting parameter for thecord, increased up to 3% (~100 cGy) for 1 cmsuperior-inferior displacement of the jaws and increasedslightly with the increase in jaw displacement.Outward displacement of all four jaws resulted in amuch higher increase in mean dose to the OARs thanonly with one jaw pair displacement. Such increase washigher for larger displacement of both jaw pairs. Effectof 2 cm jaw displacement on DVHs for a few criticalstructures of a representative patient is shown in Figure4.
Figure 4: Comparison of the effect of outward displacementof all 4 jaws by 2 cm against no (zero) displacement (dose isnormalized with respect to the highest dose among theOARs).
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Figure 5: Effect of outward displacement of all four jaws by1 and 2 cm on mean dose to OARs.Increase in mean dose to various structures averagedover 10 patients is presented in Figure 5. As evidentfrom Figure 5, increase in mean dose to OARs averagedover 10 patients ranged from 1.5 to 4.3% for 1 cmoutward displacement of all 4 jaws and the valuesalmost doubled for 2 cm displacement. But the increasewas 0.0% for PTV in both cases. Among the patientsstudied, the increase in mean dose to stomach for 1 cmjaw displacement was as high as 144 cGy. The increasein mean dose to other structures in some patientsranged as high as 50-100 cGy. Such increases arestatistically significant and can have clinical significancein some structures. The increase in mean dose to someof the OARs in few patients were much larger than theaveraged values displayed in the figures. Since such alarge increase may occur in any patient, a carefulconsideration should be given to minimize it.
4. DiscussionOur study did not show any obvious correlation betweenthe percentage increase in mean dose to the OARs andany other clinical parameters such as PTV size. It isobvious that PTV shape and location differ with patients.Hence portion of the critical structures lying underneaththe gap between the inner extent of MLCs and jawsvaried with complexity of the PTV shape. This variationin gap resulted in a different amount of increase in meandose to the OARs. The increase in absolute dose to theOARs increases with the increase in MUs for the samefield size provided the area between MLC leaf end andjaw position is constant. It also depends on the numberof fields and size of the field. However, the area betweenMLC ends and jaws changes with complexity of thetarget shape resulting in a varying transmission.Treatment parameters including the field size, numberof fields and the number of MUs depend on the size,shape and location of the target, beam modulation andprescription dose, leaving the treatment planner withless choice. However, area between MLC leaves and jawposition can always be minimized to reduce dose to theOARs.
Generally, MLCs conform to the outer extent of a blockmargin and a few millimeter gap between inner extent ofMLCs and the collimator jaws is typical in a 3DCRT plan.However, there can be a different scenario in somecases. As an example, if a planner decides to reduce themargin around the PTV, MLCs move to conform to thenew block margin leaving the jaws in their originalposition. Some treatment planning systems such asEclipse do not allow a merger of fields with different jawdefined field sizes. Hence the usage of subfields in a fielddoes not reduce the gap between a block margin and thejaws and the leakage dose around the treatment targetdoes not decrease. In addition, the use of an EDW inVarian machines requires a minimum of 4 cm Y-jawseparation. Hence, an EDW might not permit the optimaljaw position for small target treatment. These effectsshould be carefully considered during treatmentplanning. Without a careful consideration, OARsunderneath the MLCs can receive an unnecessarilyhigher dose.The role of an optimal jaw position in reducing dose tonormal structure in 3DCRT based intracranialstereotactic radiosurgery (SRS) planning has beeninvestigated and our results are in line with the resultsfrom Han et al. 12In spite of a low dose spill outside the treatment area,IMRT and volumetric modulated arc therapy (VMAT)plans offer a good OAR sparing. VMAT provides a fasterdose delivery with OAR sparing comparable to IMRT.
13,14 Comparative studies on pancreatic cancer treatmentshow that VMAT and IMRT plans provide a better doseconformity than 3DCRT plans. In addition, VMATproduces a dose conformity comparable to IMRT whilereducing the dose delivery time the and the number ofMUs used. 15,16
5. ConclusionCollimator jaws aligned with the outer extent of a blockmargin offer the optimal position in minimizing dose toOARs during a 3DCRT delivery. Any outwarddisplacement of the jaws from the optimal position canincrease dose to OARs surrounding the treatment target.This effect is patient specific and depends on the gapbetween the inner extents of MLCs and the jaws, andtarget shape and location relative to the OARs. Even asmall outward displacement of the jaws may lead to asubstantial increase in OARs dose that may have aclinical significance.Based on the study, we highly recommend that thecollimator jaws be pulled all the way in to match withthe block outline around the target in all external beamplans including 3DCRT. Reduction in dose to normalstructures not only lowers the chances of normal tissuecomplication including the risk of secondary cancer, italso helps keep the door open for prescription radiation
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dose escalation or for a boost treatment for the bettertumor control.
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